Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th
December 02, 2021 08:30 ET | Source: Mindset Pharma Inc. TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company“), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that it […]
Silo Pharma Announces Grant of U.S. Patent For its Novel CNS Homing Peptide
U.S. Patent and Trademark Office issued US Patent No. 11,174,287 investigation, detection, treatment or prevention of neuroinflammation December 02, 2021 08:10 ET | Source: Silo Pharma, Inc. Englewood Cliffs NJ, Dec. 02, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic announced the issuance […]
